Virgin Islands. CDC collected data for the 2001 BRFSS survey from 205,140 respondents (median response rate*: 51.1%; median cooperation rate † : 52.7%) and the 2005 survey from 356,112 respondents (median response rate: 51.1%; median cooperation rate 75.1%) (4) . Response rates were calculated using guidelines from the Council of American Survey and Research Organizations.
Beginning in 2001, BRFSS included biannual questions about participation in moderate and vigorous physical activities. To assess participation in moderate activities, respondents were asked if, when not working, they "do moderate activities for at least 10 minutes at a time, such as brisk walking, bicycling, vacuuming, gardening, or anything else that causes some increase in breathing or heart rate" in a usual week. Respondents who answered "yes" were asked how many days per week they engaged in moderate activities and the amount of time spent in activities on each of those days. To assess participation in vigorous activities, respondents were asked to report whether they "do vigorous activities for at least 10 minutes at a time, such as running, aerobics, heavy yard work, or anything else that causes large increases in breathing or heart rate" in a usual week, when not working. Respondents who answered "yes" were of women reported engaging in regular physical activity, with the largest increases reported among non-Hispanic black women and men. However, among racial/ethnic groups in 2005, only non-Hispanic white men (52.3%) had reached the Healthy People 2010 target of 50% of adults engaging in regular physical activity, although nonHispanic white women (49.6%) had nearly reached that target.
The findings in this report are consistent with previous BRFSS physical-activity analyses (5) , including a decrease in leisure-time physical inactivity from 2001 to 2004 among men and women in all racial/ethnic groups (6) . These BRFSS findings and those from the previous BRFSS reports suggest that U.S. adults are becoming more physically active. However, data from the National Health Interview Survey indicate that regular leisure-time physical activity among U.S. adults decreased among men and did not change significantly among women from 2000 and 2005 (7) . Differences in format, period of recall, and activities assessed might explain the differences in results from the two surveys.
In addition to the racial/ethnic disparities, disparities in education also were observed. In 2001 and 2005, increasing education level was associated with increased prevalence of regular physical activity in both men and women. In 2005, 54.6% of men and 53.3% of women who were college graduates engaged in regular physical activity, compared with 37.2% of men and 37.1% of women with less than a high school education. Why persons with higher levels of education reported more physical activity is not clear.
The findings in this report are subject to at least four limitations. First, BRFSS data are self-reported and subject to recall bias. Second, the survey questions were not designed to assess whether a combination of moderate and vigorous physical activity met the requirement for engaging in regular physical activity when the two activity types measured separately did not; therefore, prevalences might have been underestimated. Third, the "other race" category combined multiple racial and ethnic groups. Although this approach increased the power of analysis by creating a larger group, analysis could not be extended to any individual groups included in this category. Finally, persons without landline telephones are not eligible for participation in the BRFSS and might be younger or of lower socioeconomic status (8) ; their exclusion might affect estimates of regular physical activity.
In 2005, fewer than half the adult U.S. population engaged in recommended levels of physical activity. To increase physical-activity levels in the United States, CDC encourages states to implement evidence-based intervention strategies such as those described in the Guide to Community Preventive Services. § Examples of recommended intervention strategies include communitywide campaigns, point-of-decision prompts, social support for physical activity, and enhanced access to places to be physically active combined with informational outreach. Certain communities have successfully implemented these strategies to increase physical-activity levels. For example, Marin County, California developed a multipronged approach to encourage children and parents to walk or bike to schools daily (9) . As a result, participating schools reported an increase in trips made by walking (64%) and biking (114%).
Despite increases in prevalence of physical activity among minorities, racial/ethnic disparities persist. Many persons in racial/ethnic minority groups are at increased risk for heart disease, hypertension, and diabetes, all of which have been linked to low levels of physical activity (10) . To help eliminate racial and ethnic disparities in health, CDC implemented REACH Across the United States (REACH US) as a national, multilevel program. REACH US communities have implemented culturally appropriate, community-based, physical-activity interventions, including free classes, walking clubs, and faith-based nutrition and activity programs. State and local public health agencies should consult the Community Guide to Preventive Services and successful REACH US communities for examples of culturally appropriate, evidence-based initiatives to further increase physical-activity levels among racial and ethnic minorities.
Norovirus Outbreak Associated with Ill Food-Service WorkersMichigan, January-February 2006
On January 30, 2006, the Barry-Eaton District Health Department (BEDHD) in Michigan was notified of gastrointestinal illness in several members of two dining parties after a meal at an Eaton County restaurant on January 28. An investigation was initiated by BEDHD to identify the source and agent of infection and to determine the scope of illness among patrons and employees of this national chain restaurant. Norovirus genogroup I (GI) was detected in stool specimens submitted by multiple patrons and employees. The investigation revealed that several foodservice workers had been ill during January 19- February 3, 2006 , and that a line cook had vomited in the restaurant on January 28, possibly increasing environmental contamination and transmission of virus. This report summarizes the findings of the outbreak investigation, which determined that at least 364 restaurant patrons had become ill. The findings underscore the need for 1) ongoing education of food-service workers regarding prevention of norovirus contamination and transmission; 2) enforcement of policies regarding ill and recently ill food-service workers; and 3) environmental decontamination with effective disinfectants to eliminate the presence of norovirus.
After learning of the outbreak on January 30, BEDHD launched an epidemiologic and environmental assessment.
The restaurant was open for dinner on weekdays and lunch and dinner on weekends and served up to 800 persons daily with a staff of 32-50 employees. Initial investigation indicated that the index case was in an employee who worked as a server at the restaurant and became ill with symptoms of vomiting on or around January 19. Work records indicated that this employee did not work while ill. A second employee (a sibling to the server) became ill with abdominal cramps, diarrhea, and vomiting on January 21 and § Available at http://www.thecommunityguide.org/pa. worked on the first and second days of illness; this person's duties included bartending and administrative work. Seven patrons reported that they had eaten at the restaurant during January 21-27. On January 28, a line cook (line cook A) vomited at home (at approximately 6:00 a.m.) before reporting to work at 11:00 a.m., then vomited again into a waste bin beside the frontline workstation at approximately 2:00 p.m. while preparing antipasti platters, pizzas, and salads. After vomiting, line cook A remained on site (but off the cooking line) and left work at 4:15 p.m. This person also reported to work on January 29 from 11:00 a.m. to 4:30 p.m. while still experiencing loose stools.
BEDHD began case finding by obtaining names of patrons from credit card receipts, records of delivery and catering events, and records of dinner reservations; information on patrons without reservations or those who paid with cash was not available. Using Internet-based telephone directories, BEDHD contacted patrons who dined at or consumed food prepared by the restaurant during January 19-February 3. Many patrons contacted BEDHD as a result of the extensive media coverage. BEDHD staff members administered patron interviews by telephone; the interviews included questions about basic demographics, date and time of the restaurant meal, food history, and illness history. Restaurant employees were interviewed in person or by telephone and additionally asked about their work schedules for this period.
BEDHD conducted two studies: 1) a descriptive study to characterize ill persons and 2) an analytic study to determine whether certain foods were associated with illness. Because only a portion of restaurant patrons could be identified or contacted, a case-control methodology was used for the analytic study.
For the descriptive study, a case in a patron was defined as illness in a patron who had eaten food prepared at the restaurant during January 19-February 3 and who had become ill with vomiting or diarrhea within 10-50 hours (1) after eating the food. A case in an employee was defined as illness in an employee who was ill with vomiting or diarrhea during January 19-February 3, regardless of the incubation period. To determine whether any changes occurred in rates of illness among patrons based on the time the meal was eaten, attack rates were calculated in 3-hour intervals for January 28 and 29, by dividing the number of cases in patrons who dined during each time interval by the number of meals served for those periods.
For the analytic study, a case-patron was defined as a patron who had eaten food prepared at the restaurant during January 28-29 (the 2 days line cook A worked while symptomatic) and subsequently became ill with vomiting or diarrhea 10-50 hours after eating; a control was a patron who had the same exposure but no gastrointestinal illness. Statistical software was used to perform the analysis. Chi-square and Fisher's exact tests were used in the case-control analysis.
Stool specimens, obtained from patrons and employees, were tested for norovirus RNA by reverse transcriptasepolymerase chain reaction (RT-PCR) and for bacterial pathogens at the Michigan Department of Community Health (MDCH). All positive RT-PCR specimens were genotyped by sequence analysis.
Descriptive Study
A total of 625 persons were interviewed by BEDHD: 584 patrons (113 were well), 32 employees, and nine additional persons who became ill after contact with a patron or employee in whom a case was identified. A total of 364 patrons of the 584 interviewed met the descriptive study case definition; the median age was 40 years (range: 1-92 years), 58.5% were female, 88.2% reported diarrhea, 71.7% reported vomiting, and the median duration of illness was 42 hours (range: 2-172 hours) (Table) . Patron onset of illness peaked during 12:00 a.m.-3:59 a.m. on January 30 (Figure 1 ). The median time from a meal at the restaurant until onset of symptoms was 32 hours. The number of cases was already decreasing on January 30, when BEDHD was notified and interventions were implemented.
A total of 281 patrons in whom cases were identified had dined on January 28, resulting in an attack rate of 33.7%; on January 29, the attack rate was 13.5% (64 cases divided by 475 meals). Analysis of patron illness based on date and time that the meal was eaten demonstrated that norovirus transmission was occurring in the restaurant before the vomiting incident on January 28 (Figure 2 ). The attack rate was highest for patrons who ate during 5:00 p.m.-7:59 p.m. on January 28. Transmission continued through the next day. 
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Of the 32 employees interviewed, cases were identified in 17 (53.1%). Seven (41.2%) of these 17 employees had worked while ill during January 21-30. Twelve employees (other than line cook A) worked on January 28 and subsequently became ill. Five (62.5%) of the eight line cooks who worked on January 28 became ill on or after January 28, compared with six (28.6%) of 21 servers.
Analytic Study
In the case-control study of patrons from the period January 28-29, a total of 45 were classified as casepatrons, and 91 were classified as controls. Two foods were found to have a statistically significant association with illness: the antipasti platter (odds ratio [OR] = 2.96; 95% confidence interval [CI] = 1.08-8.14) and garlic mashed potatoes (OR = 4.05; CI = 1.37-11.99). Eighteen patrons (10 who were ill and eight who were well) reported eating the antipasti platter. Sixteen patrons (10 ill and six well) reported eating the garlic mashed potatoes.
Nine persons who had not eaten or worked at the restaurant became ill after contact with either a case-patron or case-employee (i.e., household or work contacts). Eight of these nine persons had symptoms of vomiting or diarrhea with illness onset during January 30-February 7.
All 14 stool specimens tested by RT-PCR were positive for norovirus GI. The companion bacterial samples tested negative. Results from the sequence analysis, using the degenerative primer set to produce a 213-bp amplicon of region B of the norovirus genome, demonstrated 100% sequence homology with the genotype GI/4 Chiba.
Environmental Assessment
The BEDHD environmental assessment of the restaurant identified deficiencies with employee hand-washing practices, cleaning and sanitizing of food and nonfood contact surfaces, temperature monitoring and maintenance of potentially hazardous food, and maintenance of hand-sink stations for easy accessibility and proper use. Three Editorial Note: Norovirus can be transmitted person-toperson (via the fecal-oral route) and spread through contaminated airborne droplets, food, water, environmental surfaces, and fomites (3). In the outbreak described in this report, at least 364 restaurant patrons became ill with gastroenteritis after dining at a restaurant where employees had reported to work while ill. In a norovirus outbreak, a vomiting incident is a major risk factor for norovirus illness and can double the attack rate (4) . In this outbreak, vomiting by a line cook at the work station might have contributed to transmission. Because of the open physical layout of the restaurant, no barrier impeded airborne spread of the virus from the kitchen to the main dining area. Attack rates increased after this incident, and among employees who worked on January 28, a higher percentage of line cooks became ill compared with servers. In addition, other environmental contamination probably contributed to transmission. Low-level transmission was occurring in the week before January 28; seven patrons who dined at the restaurant during January 21-27 met the case definition. During January 21-February 3, exposure to virus likely occurred by contact with contaminated surfaces and objects. Foodborne transmission also might have contributed to the outbreak. The antipasti platter (a combination of calamari, bruschetta, and mozzarella cheese sticks with marinara sauce) was one of many dishes that line cook A prepared but the only item among those line cook A prepared that had a statistically significant association with illness. The other food that was linked with illness was the garlic mashed potatoes. However, only a small proportion of patrons ate either of these items.
Feline calicivirus, a proxy virus used for norovirus research, can persist in the environment for 21-28 days and is resistant to inactivation by certain cleaning agents (e.g., quaternary ammonium-based sanitizers) (5) . In this outbreak, the restaurant's use of cleaning cloths soaked with a quaternary ammonium-based cleaning product likely was ineffective in disinfecting the restaurant (6) Food Code includes norovirus as one of several highly pathogenic organisms that can be easily spread by ill food handlers and provides disease-specific conditions for work exclusion, restriction, and reinstatement.
After the outbreak described in this report, BEDHD issued four recommendations (based on previously * The Environmental Protection Agency has approved the claims of effectiveness against norovirus of several antimicrobial disinfectants. Some of these products include quaternary ammonia-based disinfectants but are in combination with alcohols. These claims of effectiveness are based on in vitro studies that typically use a proxy virus (e.g., feline calicivirus); field effectiveness in the context of outbreaks has not been evaluated. A list of these products is available at http:// www.epa.gov/oppad001/list_g_norovirus.pdf. † Available at http://www.michigan.gov/mda/1,1607,7-125-1568_2387_2435---,00.html. § Available at http://www.cfsan.fda.gov/~dms/fc05-toc.html.
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published guidelines [9] ) for infection control and environmental decontamination after any vomiting incident in a food-service establishment. First, any exposed food or single-service articles (e.g., drinking straws, takeout containers, and paper napkins) should be discarded, and all surface areas within at least a 25-foot radius of the vomiting site should be disinfected with a bleach solution (2) . Second, ill employees should be excluded from work for at least 72 hours after symptoms subside, and employees returning after a gastrointestinal illness should be restricted from handling kitchenware or ready-to-eat food for an additional 72 hours. Third, because thorough disinfection might be necessary, partial or complete closure of the food establishment should be considered after a vomiting incident. Finally, restrooms used during or after a vomiting incident should be closed immediately until they are disinfected properly with bleach solution.
Notice to Readers

National Influenza Vaccination WeekNovember 26-December 2, 2007
To help raise awareness regarding the importance of obtaining influenza vaccination throughout the entire influenza season, the U.S. Department of Health and Human Services, National Influenza Vaccine Summit, CDC, and other partners are conducting activities during the second annual National Influenza Vaccination Week (NIVW), November 26-December 2.
Influenza vaccination coverage in all groups recommended for vaccination remains suboptimal. Despite the timing of the peak of influenza disease, administration of vaccine decreases substantially after November. According to results from the National Health Interview Survey regarding the two most recent influenza seasons, approximately 84% of all influenza vaccinations were administered during September-November* ( Figure) . Among persons aged >65 years, the percentage of September-November vaccinations was even higher, at 92% (CDC, unpublished data, 2007). Because many persons recommended for vaccination remain unvaccinated at the end of November, CDC is encouraging public-health partners and health-care providers to conduct vaccination clinics and other activities that promote influenza vaccination during NIVW and throughout the remainder of the influenza season.
Each year, on average, approximately 15-60 million persons in the United States are infected with influenza virus; an estimated 200,000 persons are hospitalized from influenza complications, and an estimated 36,000 persons die from those complications (1) . Influenza vaccination is the best way to prevent influenza and potentially severe complications. CDC recommends that anyone who wants to reduce their risk for influenza infection should be vaccinated every influenza season. Annual vaccination is particularly important for the following groups (1).
• persons at high risk for influenza-related complications and severe disease, including: -children aged 6-59 months, -pregnant women, -persons aged >50 years, -persons of any age with certain chronic medical conditions; and • persons who live with or care for persons at high risk, including: -household contacts and caregivers of persons in the above groups, -household contacts and caregivers of children aged <6 months (these children also are at high risk for influenza-related complications but are too young to receive influenza vaccination), and -health-care workers.
The time to receive influenza vaccination starts when vaccine becomes available in the local community and continues into January or later, when the influenza season typically peaks. Throughout NIVW, CDC will be highlighting the importance of influenza vaccination for persons at high risk, their close contacts, and all those who want to be protected from influenza. CDC, Families Fighting Flu, and other partners also have designated Tuesday, November 27, as Children's Flu Vaccination Day to put a special focus on the importance of vaccinating children at high risk and their close contacts.
NIVW posters and other influenza educational materials are available to download for local printing and distribution at http://www.cdc.gov/flu/professionals/flugallery. Other influenza-related tools and information for healthcare professionals and patients are available at http:// www.cdc.gov/flu. (1) . Expanding the age indications to include healthy children aged 2-4 years provides another influenza vaccination option for young children. In granting the new approval, FDA emphasized that FluMist is not approved for vaccination of children aged <2 years or adults aged >49 years, and that FluMist safety has not been established in persons with underlying medical conditions predisposing them to influenza-related complications (2) . In addition, FluMist should not be administered to persons with asthma or children aged <5 years with recurrent wheezing (1,2). 
New Recommendation for FluMist
In a randomized trial published in 2007, FluMist and trivalent inactivated vaccine (TIV) were compared among children aged 6-59 months (3). Children with medically diagnosed or treated wheezing within 42 days before enrollment, or a history of severe asthma, were excluded from this study. FluMist had a 55% (95% confidence interval [CI] = 45%-63%) greater efficacy compared with TIV in preventing culture-confirmed influenza illness.
In the trial, among children aged 6-23 months, wheezing that required bronchodilator therapy or that was associated with significant respiratory symptoms occurred in 5.9% of FluMist recipients, compared with 3.8% of those who received TIV (risk ratio [RR] = 1.5, CI = 1.2-2.1). Wheezing was not greater among children aged 24-59 months who received FluMist (3). In a previous randomized placebo-controlled safety trial among children aged 12 months-17 years, an elevated risk for asthma events (RR = 4.06, CI = 1.29-17.86) was noted among 728 children aged 18-35 months who received FluMist; of the 16 children with asthma-related events, none required hospitalization, and elevated risks for asthma were not observed in other age groups (4).
During 2006-2007, the Advisory Committee on Immunization Practices (ACIP) influenza vaccine workgroup reviewed data on the use of FluMist among children aged 2-4 years. On the basis of these data, expert opinion of the workgroup members, and consultation with representatives from the American Academy of Pediatrics and immunization safety experts, the workgroup revised recommendations for use of LAIV to include children aged 2-4 years, and presented its recommendations to ACIP. On October 24, 2007, ACIP recommended that either LAIV or TIV can be used to vaccinate healthy nonpregnant persons aged 2-49 years. For the purposes of this recommendation, healthy persons were defined as persons who do not have an underlying medical condition that predisposes them to influenza complications (5) . ACIP also approved use of FluMist for healthy persons aged 2-18 years under the federal Vaccines for Children (VFC) program.
Although FDA licensure of FluMist excluded children aged 2-4 years with a history of asthma or recurrent wheezing, the precise risk, if any, of wheezing caused by FluMist among these children is unknown because experience with FluMist among these young children is limited. Young children might not have a history of recurrent wheezing if their exposure to respiratory viruses has been limited because of their age. Certain children might have a history of wheezing with respiratory illnesses but have not had asthma diagnosed. The ACIP influenza vaccine workgroup, with advice from consultants, developed the following screening recommendations to assist persons who administer influenza vaccines in providing the appropriate vaccine for children aged 2-4 years.
Clinicians and immunization programs should screen for possible reactive airways diseases when considering use of FluMist for children aged 2-4 years, and should avoid use of this vaccine in children with asthma or a recent wheezing episode. Health-care providers should consult the medical record, when available, to identify children aged 2-4 years with asthma or recurrent wheezing that might indicate asthma. In addition, to identify children who might be at greater risk for asthma and possibly at increased risk for wheezing after receiving LAIV, parents or caregivers of children aged 2-4 years should be asked: "In the past 12 months, has a health-care provider ever told you that your child had wheezing or asthma?" Children whose parents or caregivers answer "yes" to this question and children who have asthma or who had a wheezing episode noted in the medical record within the past 12 months, should not receive FluMist. TIV is available for use in children with asthma or possible reactive airways diseases.
Other Changes in FluMist Use for 2007-08
Three other changes in the use of FluMist and its 2007-08 formulation should be noted; the amount of vaccine administered, the temperature at which FluMist is shipped and stored after delivery to the end-user, and the minimum interval between doses have changed compared with the 2006-07 influenza season formulation. First, FluMist is now supplied in a prefilled, single-use sprayer containing 0.2 mL of vaccine instead of the previous 0.5 mL dose. Persons administering FluMist should spray 0.1 mL (i.e., half of the total sprayer contents) into the first nostril while the recipient is in an upright position. An attached dose-divider clip should then be removed from the sprayer and the second half of the dose administered into the other nostril. Second, FluMist is now approved to be shipped to end users at 35°F-46°F (2°C-8°C) instead of being shipped and stored frozen. FluMist should be stored at 35°F-46°F (2°C-8°C) upon receipt, and can remain at that temperature until the expiration date is reached. (2) Third, the recommended interval from the first to the second dose in children requiring 2 doses has changed from a minimum of 6 weeks to a minimum of 4 weeks, the same interval recommended between doses for TIV (2) .
Regardless of the vaccine used, ACIP, the American Academy of Pediatrics, and the American Academy of Family Physicians recommend that children aged <9 years who have not previously been administered an influenza vaccine should receive 2 doses separated by 4 or more weeks in the initial year (6) . Children aged <9 years who did not receive the recommended second dose of influenza vaccine in the initial year that they received influenza vaccine should receive 2 doses separated by 4 Afluria is available in a 0.5 mL preservative-free, singledose, prefilled syringe and in a 5 mL multidose vial containing 10 doses. Thimerosal, a mercury derivative, is added as a preservative to the multidose vial; each 0.5 mL dose contains 24.5 µg of mercury. Additional information is available from the manufacturer's package insert (3) and CSL Biotherapies, Inc., telephone 888-435-8633.
Notice to Readers
Satellite Broadcast: Surveillance of Vaccine-Preventable Diseases 2007
On December 13, 2007, CDC and the Public Health Training Network will present the satellite broadcast and webcast, Surveillance of Vaccine-Preventable Diseases 2007. The 3.5-hour broadcast will occur live from 9:00 a.m. to 12:30 p.m. EST. This program is designed to provide information on case investigation, outbreak control, and disease reporting for vaccine-preventable diseases, and will discuss methods of enhancing surveillance and completing case investigations. The program is specifically targeted to persons with surveillance responsibilities (e.g., those in state health departments). The broadcast will feature a live question-and-answer session in which participants nationwide can interact with course instructors via toll-free telephone lines. Continuing education credits will be provided. Additional information about the program is available at http://www2a.cdc.gov/phtn/vpd-07.
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